Vimarsana
Biggest News Aggregation in the World

Page 17 - Pro Solutions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pro Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pro Solutions Today - Breaking & Trending Today

Oil Gas Producer TAQA North Chooses InterPro's EZMaxMobile To Identify And Correct Hazardous Conditions In The Moment - Vimarsana News

Oil Gas Producer TAQA North Chooses InterPro's EZMaxMobile To Identify And Correct Hazardous Conditions In The Moment

Case Study Oil & Gas Producer TAQA North Chooses InterPro's EZMaxMobile To Identify And Correct Hazardous Conditions In The Moment Safety incident reporting increased 100 percent within one month Objectives: Given the extensive, remote locations of their operations, TAQA North required a mobile solution to complement the main Maximo platform upon which the HSSE solution would be built. The mobile solution needed to: Have an offline, disconnected mode, since many of the TAQA North locations are out of cell range. Be seamless with Maximo by utilizing the Maximo logic and bus...

Herc Holdings Inc. (HRI) Q4 2020 Earnings Call Transcript - Vimarsana News

Herc Holdings Inc. (HRI) Q4 2020 Earnings Call Transcript

Operator Good day and welcome to the Herc Holdings Inc Fourth Quarter 2020 Earnings Conference Call. [Operator instructions] I would now like to turn the conference over to Elizabeth. Please go ahead. Elizabeth Higashi -- Vice President of Investor Relations Thank you, Grant. And thank you all for joining us this morning. Welcome, everyone, to our fourth quarter and full year 2020 earnings conference call. Earlier today, our press release, presentation slides and 10-K were filed with the SEC and are all posted on our IR website at ir.hercrentals.com. This morning, I'm joined by Larry Silber,...

Source: fool.com
InterPro Expands Offerings With New Solution for Managing Operations and Maintenance Activities Across Mixed Workforces - Vimarsana News

InterPro Expands Offerings With New Solution for Managing Operations and Maintenance Activities Across Mixed Workforces

InterPro Expands Offerings With New Solution for Managing Operations and Maintenance Activities Across Mixed Workforces EZMaxVendor enables organizations to manage tradespeople, contractors and service vendors as an extension of their own workforce News provided by Share this article Share this article BOSTON, Feb. 9, 2021 /PRNewswire/ -- InterPro Solutions, which offers the only suite of mobile solutions designed exclusively for IBM Maximo®, expanded its EZMax Suite today with a new Field Service Management offering targeted at managing mixed workforces. InterPro's new EZMaxVendor app allo...

Pfizer-Mylan combo Viatris to slash up to 9,000 jobs, shutter manufacturing plants in global cost-cutting drive - Vimarsana News

Pfizer-Mylan combo Viatris to slash up to 9,000 jobs, shutter manufacturing plants in global cost-cutting drive

Dec 11, 2020 10:23am Viatris' restructuring efforts could impact up to 20% of its 45,000-strong workforce, putting up to 9,000 jobs on the line. (Pixabay) A little less than a month after Pfizer's Upjohn unit and Mylan successfully merged to create generics business Viatris, the company is already looking at ways to slash costs. Newly minted Viatris Friday laid out detailed plans for a global manufacturing initiative that could put thousands of jobs on the line. By 2024 at the latest, the company aims to wring at least $1 billion from its cost base, and it's planning to close, downsize or d...

FiercePharmaAsia—Takeda's CMV, leukemia data; COVID-19 vaccines from Sinovac, Clover and Sinopharm - Vimarsana News

FiercePharmaAsia—Takeda's CMV, leukemia data; COVID-19 vaccines from Sinovac, Clover and Sinopharm

Dec 11, 2020 9:25am Takeda and COVID-19 vaccines from Chinese firms Sinovac, Clover Biopharma and Sinopharm made our news this week. (Google) Takeda's cytomegalovirus candidate, TAK-602, hit its phase 3 goal in transplant patients. The Japanese pharma's Iclusig posted new chronic myeloid leukemia data, touting five-year survival in 60% of patients. China-made COVID-19 vaccines had a busy week: Sinovac plans to double its COVID-19 capacity with a new, $515 million investment from Sino Biopharma; Clover Biopharma kicked off a pivotal trial of its S-Trimer vaccine paired with a GlaxoSmithKline...